05 Nov 2019 - 06 Nov 2019

Meningitis and septicaemia 2019

London, UK, England
Conference & symposium
Register for Conference online

About the event

We are pleased to announce that Meningitis Research Foundation’s 12th International Conference will be held at The British Museum, Great Russell Street, London on 5-6th of November, 2019.

Our twelfth international conference brings together world leading experts to share the latest advances and discuss today’s challenges for meningitis and septicaemia.

Around 300 delegates from a range of specialties and international institutions will join us at the British Museum for two days of presentations from renowned leaders in their field, lively panel discussions and poster presentations that showcase talent, in-depth knowledge and cutting-edge research.

This key event for world leading authorities in infectious disease, paediatrics, vaccinology, public health and tropical medicine also offers excellent opportunities to network and share opinions.

A.

DRAFT PROGRAMME - Meningitis and Septicaemia 2019
Tuesday 5 & Wednesday 6 November 2019, British Museum, London.

Day 1 – Tuesday 5 November
8:00 – 9.00 Registration and coffee
9.00 Welcome, Vinny Smith, Chief Executive Meningitis Research Foundation (MRF)

The need for action on meningitis: burden of illness Chair: Professor Sir Brian Greenwood,  London School of Hygiene and Tropical Medicine

9.20-9.40 Patient experience of meningococcal disease TBD, member of MRF
9.40-10.05 Global burden of meningitis, understanding modelling estimates and the Meningitis Progress Tracker Claire Wright, MRF
10.05-10.30 Estimating global burden of pneumococcal, Hib, & meningococcal infection Dr Maria Knoll, Johns Hopkins Bloomberg School of Public Health
10.30-10.55 Neonatal sepsis in Africa and LMICs Dr Anna Seale, London School of Hygiene and Tropical Medicine


10.55-11.25 COFFEE, EXHIBITION AND POSTERS


WHO Global Roadmap to Defeat Meningitis by 2030


11.25-11.50 Update on the WHO Global Roadmap to Defeat Meningitis by 2030 – goals, milestones, activities, insights from consultation, Dr Marie-Pierre Preziosi WHO

Prevention and epidemic control (1) – Chair: Dr Caroline Trotter,  University of Cambridge

11.50-12:15 Update on meningococcal prevention in the meningitis belt, what next for MenACWYX vaccine? Trial update, modelled impact of mass vaccination and infant programme, further studies planned and decisions on strategy Dr Marc LaForce, Serum Institute of India
12.15-12:40 Update on global prevention of pneumococcal infection; expanded conjugate vaccines and new pneumococcal protein vaccines, implications of Gavi graduation, and serotype replacement Dr Mark Alderson, PATH
12:40-13:00 Modelling the use of ciprofloxacin for epidemic response in the African meningitis belt Dr Matt Coldiron, Epicentre, Médecins Sans Frontières

13.00-14.00 LUNCH, EXHIBITIONS AND POSTERS

Prevention and epidemic control (2)– Chair: Prof Paul Heath, St George’s University of London

14.00- 14.40 Debate - Pneumococcal vaccination: is a second year of life booster needed for herd protection? Prof Adam Finn, University of Bristol vs Prof Andrew Pollard, University of Oxford
14.40-15.05 Impact of the UK meningococcal B and ACWY immunisation programmes and genotypic enhanced surveillance of IMD in England Dr Shamez Ladhani, Public Health England
15.05-15.30 Group B Streptococcal disease: evidence on consequences of screening vs risk based strategy for antibiotic prophylaxis, and the national UK trial of clinical and cost-effectiveness of screening Dr Kate Walker, University of Nottingham


15.30-16.00 TEA, EXHIBITIONS AND POSTERS

Prevention and epidemic control (3) – Chair: Dr Matthew Snape, University of Oxford

16.00-16.20 Prospect for a GBS vaccine and the pathway to licensure, including considerations for LMICs Dr Kirsty Le Doare, St George’s University of London and Mulago Hospital, Uganda
16.20-16.40 Update on findings from the pneumococcal challenge model Dr Andrea Collins, Liverpool School of Tropical Medicine
16.40-17.00 Update on the Neisseria lactamica challenge model Prof Rob Read, University of Southampton

17.00-17.50 Pfizer satellite symposium

17.50-19.00 Evening wine reception for all delegates and participants

Day 2 – Wednesday 6 November

8.00 Registration and coffee

Diagnosis and Surveillance – Chair: Prof Dominique Caugant, Norwegian Institute of Public Health

9.00-9.25 Update on the development of rapid diagnostic tests for meningitis Dr Olivier Ronveaux, WHO
9.25-9.50 Role of metagenomics in undiagnosed meningitis, Dr Senjuti Saha, Child Health Research Foundation and Dhaka Shishu (Children) Hospital, Bangladesh
9.50-10.15 Surveillance of paediatric meningitis Prof Martin Antonio, MRC Unit the Gambia at LSHTM
10.15-10.40 The detection of multiple meningitis pathogens, next-generation tools and new explorations Dr Brenda Kwambana, University College London and Medical Research Council/London School of Hygiene and Tropical Medicine Gambia

10.40-11.10 COFFEE, EXHIBITION AND POSTERS

Diagnosis and treatment– Chair: Dr Simon Nadel, St Mary’s Hospital/Imperial College London

11.10-11.35 Advances and controversies management of meningitis and sepsis Prof Mike Levin, Imperial College London
11.35-12.00 Cryptococcal meningitis treatment and diagnosis- demonstrating need for adjunctive therapies / follow on from treatment trial Prof Joe Jarvis, LSHTM/Botswana
12.00-12.40 Debate: Should adjunctive therapies for bacterial meningitis be used in LMICs? Dr Matt Coldiron, Epicentre, Médecins Sans Frontières vs Prof Rob Heyderman, University College London

12:40-13:40 LUNCH, EXHIBITION AND POSTERS

13:40-14:20 Poster presentations from the top 5 poster abstracts and award for the best poster -Chair: Prof James Stuart, WHO

Support and care for people and their families after meningitis - Chair: Dr Mary Ramsay, Public Health England

14.20-14.45 Meningitis sequelae, their impact, and follow up care in low income countries – how much do we know? - Dr Suzanne Anderson, Guys and St Thomas' Community Child Health
14.45-15.10 Neurodevelopmental and other impairments following neonatal meningitis or sepsis including Group B Streptococcus, Prof Joy Lawn, London School of Hygiene and Tropical Medicine

15.10-15.40 COFFEE, EXHIBITION AND POSTERS

Scientific advances – Chair: Prof Ray Borrow, Public Health England

15.40-16.05 Genomics: the power of WGS as a research and public health tool on a global scale and the GMGL initiative and consensus statement Prof Martin Maiden, University of Oxford
16.05-16.30 When two worlds (meningococcal and gonococcal) collide Dr Jay Lucidarme, Public Health England
16.30-16.55 The new generation of complement inhibitors and implications for clinical practice and vaccination policy Dr Muhamed-Kheir Taha, Institut Pasteur,
16.55-17.20 Impact of climate change on the epidemiology of meningitis Dr Madeleine Thomson, Wellcome Trust

17.20-17.25 Closing remarks, Vinny Smith, MRF

Industry sponsors: Pfizer, GSK

A.

Dr Mark Alderson, PATH
Professor Ray Borrow, Public Health England, Vaccine Evaluation Unit, Manchester
Professor Dominique Caugant, NIPH
Professor Adam Finn, University of Bristol
Professor Sir Brian Greenwood, LSHTM
Professor Paul Heath, SGUL
Professor Robert Heyderman, UCL
Dr Brenda Kwambana Adams, UCL
Dr Simon Nadel, St Mary’s Hospital / Imperial College London
Dr Olivier Ronveaux, WHO
Professor James Stuart, WHO
Dr Matthew Snape, Oxford Vaccine Group
Dr Caroline Trotter, University of Cambridge
Linda Glennie, Meningitis Research Foundation

Conference fees

The conference fees include coffee, buffet lunch and afternoon tea (both days), wine reception on day one and satellite meetings (TBC).

Standard non-commercial rate with early booking discount before 2 September

  • One day - £175
  • Both days - £270

Discount

For junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.

  • One day - £130
  • Both days - £200

Commercial

For those working in a commercial environment, including the pharmaceutical industry.

  • One day - £275
  • Both days - £370

Booking Form

Fill out the form and then send it to:

Meningitis Research Foundation
Newminster House
27-29 Baldwin Street
Bristol BS1 1LT
UK

Or by email to:

paulg@meningitis.org

Meningitis and Septicaemia 2019 Booking Form
Paul George

Hi, I’m Paul and I’m looking after this event.

If you've got a question about your booking or would like to know more call or email me.

Call me, if you'd like to book over the phone.

Tel: +44 (0)333 405 6230

Ways you can help

Please do what you can today and help save and change the lives of thousands